Table 1 Baseline Demographic and Clinical Data
Treatment | Placebo | P value | |
|---|---|---|---|
n (female/male) | 35 (22/13) | 40 (28/12) | 0.513 |
Age (yr) | 44.5 ± 2.2 | 45.3 ± 2.0 | 0.796 |
Blood pressure (systolic/diastolic, mmHg) | 121/69 ± 2.2/1.4 | 121.6/67.1 ± 1.9/1.5 | 0.868/0.760 |
Weight (kg) | 81.8 ± 2.8 | 79.6 ± 2.9 | 0.598 |
Total Cholesterol (mmol/L) | 6.2 ± 0.1 | 6.2 ± 0.1 | 0.976 |
Triglyceride (mmol/L)* | 1.9 ± 0.1 | 1.9 ± 0.2 | 0.989 |
HDL cholesterol (mmol/L) | 1.4 ± 0.06 | 1.3 ± 0.05 | 0.806 |
LDL cholesterol (mmol/L)** | 4.1 ± 0.1 | 4.2 ± 0.1 | 0.651 |
Cholesterol/HDL ratio | 4.8 ± 0.2 | 4.8 ± 0.2 | 0.981 |
C-Reactive protein (mg/dL) | 0.35 ± 0.08 | 0.38 ± .06 | 0.817 |
Homocysteine (μmol/L) | 8.0 ± 0.3 | 7.9 ± 0.3 | 0.861 |
Insulin (pmol/L) | 56.2 ± 4.2 | 68.1 ± 9.0 | 0.273 |
Glucose (mmol/L) | 5.4 ± 0.3 | 5.3 ± 0.1 | 0.840 |